Intellipharmaceutics International Inc. (IPCI)

[Tekterra]

If FDA rejects, it be hard decision to drop Rexista and go back to the generics. Just about the only thing that can save the company is seeing the MNK deal comes to full realization with the other two drugs approved.

IPCI might have taken a big blow, but it's not down and out yet. A while back we discussed that in the worst case scenario, Rexista gets rejected they would still have the MNK deal and Facolin on the market. That was what made us believe down risk is minimal.

However, short term impact might be greater than what we think. Because, investors aren't just putting money in a company that barely breaks even. A lot invested because of Rexista potential.

We all invest because of big potentials down the road. I am afraid we might see more sell offs. For the record, I am not currently holding any shares. But, I will see where this bottom and reassess the situation before buying in.

There still the catalyst of the 2 ANDA approval that both IPCI and MNK would be interested. Odidi can't raise anymore funding making offering at this point because he would be forced to take a bad offer and it will have negative long term affect on the stock price.

The last thing we need is a delisting notice from NASDAQ and this having trouble making it back in the dollar. In my opinion, Odidi would best put all development on hold and go into cost saving until additional revenue becomes available.